Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Malignant Lymphoma

  Free Subscription

Articles published in Eur J Immunol

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    April 2021
  1. NICOLAY JP, Albrecht JD, Alberti-Violetti S, Berti E, et al
    CCR4 in cutaneous T-cell lymphoma: therapeutic targeting of a pathogenic driver.
    Eur J Immunol. 2021 Apr 3. doi: 10.1002/eji.202049043.
    PubMed     Abstract available

    November 2020
  2. BRANDL C, Angermuller S, Nitschke L
    Humanized CD22 transgenic mouse model for in vivo analysis of anti-CD22-based immunotherapy.
    Eur J Immunol. 2020;50:1834-1837.

    March 2020
  3. TRUMAN LA, Bentley KL, Ruddle NH
    Lymphotoxin targeted to salivary and lacrimal glands induces tertiary lymphoid organs and cervical lymphadenopathy and reduces tear production.
    Eur J Immunol. 2020;50:418-425.
    PubMed     Abstract available

    December 2019
  4. LABAN K, Rijken R, Hiddingh S, Mertens J, et al
    cDC2 and plasmacytoid dendritic cells diminish from tissues of patients with non-Hodgkin orbital lymphoma and idiopathic orbital inflammation.
    Eur J Immunol. 2019 Dec 16. doi: 10.1002/eji.201948370.
    PubMed     Abstract available

    November 2019
  5. LABAN KG, Kalmann R, Bekker CPJ, Hiddingh S, et al
    A pan-inflammatory microRNA-cluster is associated with orbital non-Hodgkin lymphoma and idiopathic orbital inflammation.
    Eur J Immunol. 2019 Nov 12. doi: 10.1002/eji.201948343.
    PubMed     Abstract available

    October 2018
  6. URI A, Luhder F, Kerkau T, Beyersdorf N, et al
    During acute Graft versus Host Disease CD28 deletion in donor CD8(+) , but not CD4(+) , T cells maintains anti-leukemia responses in mice.
    Eur J Immunol. 2018 Oct 15. doi: 10.1002/eji.201847669.
    PubMed     Abstract available

    July 2017
  7. DUAULT C, Betous D, Bezombes C, Roga S, et al
    IL-33-expanded human Vgamma9Vdelta2 T cells have anti-lymphoma effect in a mouse tumor model.
    Eur J Immunol. 2017 Jul 25. doi: 10.1002/eji.201747093.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.